Peter Pommer. Show Affiliations »
Abstract
Mesh: See more » Genetic Testing/methodsHumansHydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic useHyperlipoproteinemia Type II/diagnosisHyperlipoproteinemia Type II/prevention & controlMass Screening/methodsPathology, Molecular/methodsRisk Reduction Behavior
Substances: See more » Hydroxymethylglutaryl-CoA Reductase Inhibitors
Year: 2015 PMID: 25837861 PMCID: PMC4390828 DOI: 10.3238/arztebl.2015.0193a
Source DB: PubMed Journal: Dtsch Arztebl Int ISSN: 1866-0452 Impact factor: 5.594